company background image
9885 logo

YSB SEHK:9885 Stock Report

Last Price

HK$6.02

Market Cap

HK$4.1b

7D

4.0%

1Y

-22.7%

Updated

21 Dec, 2024

Data

Company Financials

9885 Stock Overview

Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. More details

9885 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

YSB Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for YSB
Historical stock prices
Current Share PriceHK$6.02
52 Week HighHK$10.98
52 Week LowHK$5.37
Beta0
1 Month Change-3.22%
3 Month Change-11.86%
1 Year Change-22.72%
3 Year Changen/a
5 Year Changen/a
Change since IPO-71.47%

Recent News & Updates

Health Check: How Prudently Does YSB (HKG:9885) Use Debt?

May 22
Health Check: How Prudently Does YSB (HKG:9885) Use Debt?

Recent updates

Health Check: How Prudently Does YSB (HKG:9885) Use Debt?

May 22
Health Check: How Prudently Does YSB (HKG:9885) Use Debt?

Shareholder Returns

9885HK HealthcareHK Market
7D4.0%-1.3%-0.5%
1Y-22.7%-17.8%19.9%

Return vs Industry: 9885 underperformed the Hong Kong Healthcare industry which returned -17.8% over the past year.

Return vs Market: 9885 underperformed the Hong Kong Market which returned 19.9% over the past year.

Price Volatility

Is 9885's price volatile compared to industry and market?
9885 volatility
9885 Average Weekly Movement9.6%
Healthcare Industry Average Movement8.3%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.6%
10% least volatile stocks in HK Market4.1%

Stable Share Price: 9885 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 9885's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20156,513Buzhen Zhangwww.ysbang.cn

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. It also engages in the wholesale and retail of pharmaceutical and healthcare products.

YSB Inc. Fundamentals Summary

How do YSB's earnings and revenue compare to its market cap?
9885 fundamental statistics
Market capHK$4.07b
Earnings (TTM)HK$1.28m
Revenue (TTM)HK$18.99b

3,173x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9885 income statement (TTM)
RevenueCN¥17.82b
Cost of RevenueCN¥16.01b
Gross ProfitCN¥1.81b
Other ExpensesCN¥1.80b
EarningsCN¥1.20m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.0018
Gross Margin10.13%
Net Profit Margin0.0068%
Debt/Equity Ratio1.5%

How did 9885 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 23:49
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

YSB Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCMB International Securities Limited